The latest cancer drugs news
Browsing: Cancer Drug News
Researchers design new technology for targeted cancer drug delivery
A team of researchers at NYU Abu Dhabi, United Arab Emirates, has developed a biocompatible,…
FDA approves new therapy for patients with previously treated multiple myeloma
Today, the U.S. Food and Drug Administration (FDA) approved isatuximab-irfc, in combination with pomalidomide and…
Scientists show drug may greatly improve cancer immunotherapy success
A study led by the University of Southampton, UK, funded by Cancer Research UK, has…
Combination Drug Therapy for Childhood Brain Tumours Shows Promise in Laboratory Models
In experiments with human cells and mice, researchers at the Johns Hopkins Kimmel Cancer Center…
Old weapon, new target: Dasatinib against angioimmunoblastic T-cell lymphoma
Researchers from the University of Tsukuba, Japan, show that angioimmunoblastic T-cell lymphoma (AITL) is dependent…
Drug used for breast and kidney cancers may also extend survival for head and neck cancers
A targeted therapy drug used for breast and kidney cancers may also extend progression-free survival…
Leukaemia drugs hold promise for treatment-resistant lung cancer
Two recently approved leukaemia drugs could be enlisted against treatment-resistant lung cancer, with a clinical…
Protected: TECENTRIQ® (atezolizumab) first immunotherapy to be reimbursed for 1L treatment of extensive-stage small cell lung cancer
This content is password-protected. To view it, please enter the password below. Password:
Novel Targeted Drug Shows Promise in Advanced Kidney Cancer
Scientists report promising activity of a novel drug that targets a key molecular driver of…
Researchers look to fungus to shed light on cancer
A fungus that attacks almond and peach trees may be key to identifying new drug…